Acute respiratory viral infections: possibilities of symptomatic therapy of patients

Acute respiratory viral infections are widespread in the human population. High contagiosity, a wide variety of pathogens, the possibility of rapid changes in the genotype of the virus and, accordingly,cause the development of drug resistance, make it possible to develop epidemics, and sometimes pandemics of SARS.The clinical picture of all acute respiratory diseases consists of local and general manifestations. Local symptoms include difficulty in nasal breathing, rhinorrhea, pain and discomfort in the throat, cough, hoarseness, stuffy ears, and lacrimation. General manifestations of SARS indicate the onset of viremia, and include an increase in body temperature, general weakness, fatigue, malaise, and headache. The mechanism of SARS development determines the  treatment tactics, including etiotropic, pathogenetic and symptomatic therapy.Domestic and international clinical recommendations indicate the  possible use of  symptomatic agents for  SARS and influenza.Symptomatic treatment is one of the areas of therapy for patients with influenza and other acute respiratory viral infections and allows you to alleviate the general condition, accelerate recovery and improve the quality of life of patients. The use of combined drugs is safer for patients thenthanmonocomponent drugs, and is safe for patients, in case the instructions for use are strictly observed. Such complex medicines, which provides control of the symptoms of colds and flu within 24 hours, as domestic drug are used for patients with SARS. Due to its components, drughas antipyretic, anti-inflammatory, analgesic, anti-allergic, angioprotective and vasoconstrictive effects. The synergism of the components of the combined drug allows to increase the effectiveness of therapy of patients with acute respiratory viral infections.

1. Aitov K.A. Clinical Pattern, Diagnosis and Treatment of Flu and ARVI. Meditsinskiy sovet = Medical Council. 2015;(2):33–37. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/116?locale=ru_RU.

2. Kiselev O.I., Tsybalova L.M., Pokrovsky V.I. (eds). Influenza: Epidemiology, Diagnosis, Treatment, Prevention. Moscow: Meditsinskoye informatsionnoye agentstvo; 2012. 496 p. (In Russ.) Available at: https://www.medlib.ru/library/library/books/747.

3. Malyy V.P., Andreychin M.A. (eds). Influenza (Seasonal, Avian, Pandemic) and Other Acute Respiratory Viral Infections. Moscow: GEOTAR-Media; 2013. 320 p. (In Russ.).

4. Wark P.A.B., Ramsahai J.M., Pathinayake P., Malik B., Bartlett N.W. Respiratory Viruses and Asthma. Semin Respir Crit Care Med. 2018;39(1):45–55. doi: 10.1055/s-0037-1617412.

5. Zaitsev A.A., Sinopalnikov A.I. Influenza: Diagnosis and Treatment. RMZH = RMJ. 2008;16(22):1494–1501. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Gripp_diagnostika_i_lechenie/.

6. Zaitsev A.A., Akimkin V.G., Tutelyan A.V., Maryin G.G. Topical Issues of Epidemiology, Pharmacotherapy, and Prevention of Acute Respiratory Viral Infections. RMZH. Meditsinskoye obozreniye = RMJ. Medical Review. 2018;(11):53–57. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Aktualynye_voprosy_epidemiologii_farmakoterapii_i_profilaktiki_ostryh_respiratornyh_virusnyh_infekciy/.

7. Denisova A.R., Maksimov M.L. Acute Respiratory Viral Infections: Etiology, Diagnosis, Modern View of Treatment. RMZH. Meditsinskoye obozreniye = RMJ. Medical Review. 2018;1(2):99–103. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Ostrye_respiratornye_virusnye_infekcii_etiologiya_diagnostika_sovremennyy_vzglyad_na_lechenie/.

8. Larina V.N., Zakharova M.I., Benevskaya V.F., Golovko M.G., Solovyev S.S. Acute Respiratory Viral Infections and Influenza: Etiology, Diagnosis and Treatment Algorithm. RMZH. Meditsinskoye obozreniye = RMJ. Medical Review. 2019;9(1):18–23. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Ostrye_respiratornye_virusnye_infekcii_i_gripp_etiologiya_diagnostika_i_algoritm_lecheniya/.

9. Smirnov V.S., Zarubaev V.V., Petlenko S.V. Biology of Pathogens and Control of Influenza and ARVI. St Petersburg: Gippokrat; 2020. 336 p. (In Russ.) Available at: https://cytomed.ru/wp-content/uploads/2020/02/biology_pathogens_control_influenza_acute_respiratory.pdf.

10. Bartlett J.G. Management of Respiratory Tract Infections. Moscow, St Petersburg: BINOM-Nevskiy dialect; 2000. 192 p. (In Russ.) Available at: https://bookree.org/reader?file=551840.

11. Karpukhin G.I., Karpukhina O.G. Diagnostics, Prevention, and Treatment of Acute Respiratory Diseases. St Petersburg: Gippokrat; 2000. 180 p. (In Russ.).

12. Avdeev S.N. Severe Forms of Pandemic Influenza A/H1N1 2009. Atmosfera. Pul’monologiya i allergologiya = Atmosphere. Pulmonology and Allergology. 2010;(4):2–10. (In Russ.) Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/pulmo/ap_4_2010_02.pdf.

13. Bilichenko T.N., Chuchalin A.G. Morbidity and Mortality of the Russian Population from Acute Respiratory Viral Infections, Pneumonia and Vaccination. Terapevticheskiy arkhiv = Therapeutic Archive. 2018;90(1): 22–26. (In Russ.) doi: 10.17116/terarkh201890122-26.

14. Vikulov G.Kh. Viral, Bacterial Respiratory Infections, Immunity and Atibiotic Therapy – What Is Common? View and Recommendation of Clinical Immunologist and Infectologist. Consilium Medicum. 2015;17(11): 35–41. (In Russ.) doi: 10.26442/2075-1753_2015.11.35-41.

15. Karpishchenko S.A., Fatalieva A.F. Modern Concept of Acute Rhinosinusitis treatment. RMZH. Meditsinskoye obozreniye = RMJ. Medical Review. 2019;9(II):93–96. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Sovremennaya_koncepciya_lecheniya_ostrogo_rinosinusita/.

16. Gurov A.V. Swelling of the Mucous Membrane of the Upper Respiratory Tract. How to Deal with It? RMZH = RMJ. 2009;(19):1254– 1259. (In Russ.) Available at: https://www.rmj.ru/articles/otorinolaringologiya/Otek_slizistoy_obolochki_verhnih_dyhatelynyh_putey__Kak_s_nim_borotysya/.

17. Egorov V.I., Savlevich E.L. The Role of Innate Immunity in the Development of Chronic Rhinosinusitis and Perspectives of Its Conservative Management. Al’manakh klinicheskoy meditsiny = Almanac of Clinical Medicine. 2016;44(7):850–856. (In Russ.) doi: 10.18786/2072-0505-2016-44-7-850-856.

18. L’vov D.K. (ed.). A Guide to Virology. Viruses and Viral Infections of Humans and Animals. Moscow: Meditsinskoye informatsionnoye agentstvo; 2013. 1200 p. (In Russ.).

19. Amlaev K.P. Influenza: Epidemiological, Diagnostic, Clinical, Therapeutic Aspects and Prevention. Vrach = The Doctor. 2020;(11):10– 14. (In Russ.) doi: 10.29296/25877305-2020-11-02.

20. Ruuskanen O., Lahti E., Jennings L.C., Murdoch D.R. Viral Pneumonia. Lancet. 2011;377(9773):1264–1275. doi: 10.1016/S0140-6736(10)61459-6.

21. Seo Y.B., Song J.Y., Choi M.J., Kim I.S., Yang T.U., Hong K.W. et al. Etiology and Clinical Outcomes of Acute Respiratory Virus Infection in Hospitalized Adults. Infect Chemother. 2014;46(2):67–76. doi: 10.3947/ic.2014.46.2.67.

22. Eremina Yu.N., Leonova M.V. An Approach to the Treatment of Colds. Farmateka. 2012;(5):30–33. (In Russ.) Available at: https://pharmateca.ru/ru/archive/article/8389.

23. Romantsov M.G., Kiselev O.I., Sologub T.V. Etiopathogenetic Pharmacotherapy of ARVI and Influenza. Lechaschiу Vrach. 2011;(2):92– 96. (In Russ.) Available at: https://www.lvrach.ru/2011/02/15435132.

24. Zaitsev A.A., Tropin A.V., Lukashkin R.V., Yatsuk V.R., Sedykh Yu.P., Klochkov O.I. Treatment of Acute Respiratory Infections in Military Personnel. Voyenno-meditsinskiy zhurnal = Military Medical Journal. 2007;328(11):15–19. (In Russ.).

25. Zaitsev A.A., Klochkov O.I. Combined Drugs in the Treatment of Acute Respiratory Viral Infections: Evaluation of Clinical and Economic Efficiency. Arkhiv vnutrenney meditsiny = The Russian Archives of Internal Medicine. 2015;(4):48–52. (In Russ.) Available at: https://www.medarhive.ru/jour/article/view/437#.

26. Berdnikova N.G. Combination Therapy for Acute Respiratory Viral Infections from the Perspective of a Clinical Pharmacologist. Meditsinskiy sovet = Medical Council. 2018;(6):66–70. (In Russ.) doi: 10.21518/2079-701X-2018-6-66-70.

27. Kryukov A.I., Turovskiy A.B., Kolbanova I.G., Musayev K.M., Karasov A.B. Guidelines for the acute respiratory viral infection treatment. RMZH = RMJ. 2019;8(I):46–50. (In Russ.) Available at: https://www.rmj.ru/articles/bolezni_dykhatelnykh_putey/Osnovnye_principy_lecheniya_ostroy_respiratornoy_virusnoy_infekcii/.

28. Romantsov M.G., Ershov F.I. Frequently Sick Children: Modern Pharmacotherapy: A Guide for Physicians. Moscow: GEOTAR-Media; 2007. 188 p. (In Russ.).

29. Davidovskaya E.I. Rational Pharmacotherapy of Respiratory Viral Infections. Meditsinskiye novosti = Medical News. 2006;(12):1– 5. (In Russ.) Available at: https://www.mednovosti.by/journal.aspx?id=139.

30. Dvoretskiy L.I. Treatment of Patients with Acute Respiratory Diseases: Is There an Alternative to Polypharmacy? Consilium Medicum. 2012;10(10):10–14. (In Russ.) Available at: https://medi.ru/info/3769/.

31. Jefferson T., Jones M.A., Doshi P., Del Mar C.B., Hama R., Thompson M.J. et al. Neuraminidase Inhibitors for Preventing and Treating Influenza in Healthy Adults and Children. Cochrane Database Syst Rev. 2014;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4.

32. Rothberg M.B., Haessler S.D., Brown R.B. Complications of Viral Influenza. Am J Med. 2008;121(4):258–264. doi: 10.1016/j.amjmed.2007.10.040.

33. Tsvetkov V.V., Golobokov G.S. Priorities of Early Pathogenetic Therapy of Flue and Sars of Other Etiology. Meditsinskiy sovet = Medical Council. 2016;(15):78–82. (In Russ.) doi: 10.21518/2079-701X-2016-15-78-82.

34. Malyshev N.A., Kolobukhina L.V., Merkulova L.N., Ershov F.I. Modern Approaches to Increasing the Effectiveness of Therapy and Prevention of Influenza and Other Acute Respiratory Viral Infections. Consilium Medicum. 2005;7(10):831–835. (In Russ.).

35. Melnikova I.Yu., Romantsov M.G. Medicines for the Treatment of Influenza and ARVI. Meditsinskiy sovet = Medical Council. 2012;(1):20–23. (In Russ.).

36. Savenkova M.S., Savenkov M.P., Afanas’eva A.A., Abramova N.A. Effects of Antiviral and Immunomodulating Treatment of Influenza, Other Acute Respiratory Viral Infections and Herpes Virus Infection. Pulmonologiya = Russian Pulmonology Journal. 2014;(5):83–93. (In Russ.) doi: 10.18093/0869-0189-2014-0-5-83-93.

37. Ilkevich T.G, Teyge S.V. The Analysis of the Modern Combined Preparations Used for the Symptomatic Treatment of Acute Respiratory Viral Infections. Nauchnyy almanakh = Scientific Almanac. 2015;(11-4):73–78. (In Russ.) doi: 10.17117/na.2015.11.04.073.

38. De Sutter A.I., van Driel M.L., Kumar A.A., Lesslar O., Skrt A. Oral Antihistamine-Decongestant-Analgesic Combinations for the Common Cold. Cochrane Database Syst Rev. 2012;(2):CD004976. doi: 10.1002/14651858.CD004976.pub3.

39. Zharkova N.E. Symptomatic Treatment of ARVI: the Future Belongs to Combined Drugs. RMZH = RMJ. 2007;15(22):1636–1638. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Simptomaticheskoe_lechenie_ORVI_buduschee_za_kombinirovannymi_preparatami/.

40. Zaitsev A.A., Kulagina I.Ts. Symptomatic Agents for the Treatment of Acute Respiratory Viral Infections. Farmateka. 2013;(4):79– 82. (In Russ.) Available at: https://lib.medvestnik.ru/articles/Simptomaticheskie-sredstva-dlya-lecheniya-ostryh-respiratornyhvirusnyh-infekcii.html.

41. Kryukov A.I., Kunelskaya N.L., Turovsky A.B. Symptomatic therapy for diseases of the upper respiratory tract. Spravochnik poliklinicheskogo vracha = Outpatient Doctor’s Reference Book. 2007;5(2):11– 18. (In Russ.).

42. Picon P.D., Costa M.B., da Veiga Picon R., Fendt L.C., Suksteris M.L., Saccilotto I.C. et al. Symptomatic Treatment of the Common Cold with a Fixed-Dose Combination of Paracetamol, Chlorphenamine and Phenylephrine: A Randomized, Placebo-Controlled Trial. BMC Infect Dis. 2013;13:556. doi: 10.1186/1471-2334-13-556.

43. Chuchalin A.G. Severe Forms of Influenza: Diagnostic and Treatment Algorithms. Pulmonologiya = Russian Pulmonology Journal. 2009;(5): 5–7. (In Russ.) Available at: https://journal.pulmonology.ru/pulm/article/view/1579/1222.

44. Shishkova V.N. Efficiency, Safety and Unjustified Polypharmacy in the Treatment of Acute Respiratory Diseases. Vrach = The Doctor. 2016;(11):50–53. (In Russ.) Available at: https://vrachjournal.ru/ru/25877305-2016-11-16.

45. Sadovnikova I.I. Some Questions of the Clinic, Diagnosis and Treatment of ARVI. RMZH = RMJ. 2005;(21):1397–1399. (In Russ.) Available at: https://www.rmj.ru/articles/obshchie-stati/Nekotorye_voprosy_kliniki_diagnostiki_i_lecheniya_ORVI/.

46. Kuznetsova O.Yu., Pleshanova Zh.V. The Place of Modern Combined Drugs in the Treatment of Acute Respiratory Viral Infections in Outpatient Practice. Consilium Medicum. 2010;12(3):93– 102. (In Russ.).

47. Pchelintsev M.V. New Clinical and Pharmacological Aspects of Symptomatic Therapy of ARVI and Influenza. RMZH = RMJ. 2009;17(14):924–927. (In Russ.) Available at: https://www.rmj.ru/articles/infektsionnye_bolezni/Novye_klinikofarmakologicheskie_aspekty__simptomaticheskoy_terapii_ORVI_i_grippa/.

48. Romantsov M.G., Kiselev O.I., Sologub T.V. Etiopathogenetic Pharmacotherapy of ARVI and Influenza. Lechaschiу Vrach. 2011;(2):92– 96. (In Russ.) Available at: https://www.lvrach.ru/2011/02/15435132.

49. Krutikhina S.B., Yablokova E.A. The Current Course of Acute Respiratory Infections and the Possibility of Pathogenetic Therapy. Meditsinskiy sovet = Medical Council. 2018;(20):14–16. (In Russ.) doi: 10.21518/2079-701X-2018-20-14-16.

50. Dvoretskiy L.I., Yakovlev S.V. Errors in Antibiotic Therapy for Respiratory Tract Infections in Outpatient Practice. Lechaschiу Vrach. 2003;(8):49– 54. (In Russ.) Available at: https://www.lvrach.ru/2003/08/4530582.

51. Ershov F.I., Kasyanova N.V., Polonsky V.O. Is Rational Pharmacotherapy of Influenza and Other Acute Respiratory Viral Infections Possible? Consilium Medicum. 2003;(5):56–59. (In Russ.).

52. Fokkens W.J., Lund V.J., Hopkins C., Hellings P.W., Kern R., Reitsma S. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(29 Suppl.):1–464. doi: 10.4193/Rhin20.600.